Building an AI platform to tackle complex diseases
Update: 2024-11-29
Description
Nick is joined by Dr.Muhunthan Thillai, the co-founder and CEO of Qureight and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company.
Dr.Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
